title: Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis.
authors: Dermatology Department, University François Rabelais, Hospital of Tours, Tours, France.
authors: C
authors: C
authors: Dannepond
authors: CNRS, GICC UMR 7292, Laboratory of Pharmacology Toxicology, Hospital of Tours, Tours, France.
authors: D
authors: D
authors: Ternant
authors: Dermatology Department, University François Rabelais, Hospital of Tours, Tours, France.|INSERM, Imagerie et Cerveau UMR U930, Tours, France.
authors: A
authors: A
authors: Maruani
authors: Dermatology Department, University François Rabelais, Hospital of Tours, Tours, France.|INSERM, Imagerie et Cerveau UMR U930, Tours, France.
authors: L
authors: L
authors: Machet
authors: CNRS, GICC UMR 7292, Laboratory of Pharmacology Toxicology, Hospital of Tours, Tours, France.
authors: G
authors: G
authors: Paintaud
authors: Dermatology Department, University François Rabelais, Hospital of Tours, Tours, France.|INRA ISP, UMR 1282, Université François Rabelais, Tours, France.
authors: M
authors: M
authors: Samimi
mesh_terms: D000328:Adult; D000368:Aged; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents; D000069285:Infliximab